Order Article Reprints

Tan E, Frew E, Cooper J, Humphrey J, Holden M, Mand AR, Li J, Anderson S, Bi M, Hatler J, et al. Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs. Diagnostics. 2021; 11(7):1190. https://doi.org/10.3390/diagnostics11071190

Tan, Enqing, Erica Frew, Jeff Cooper, John Humphrey, Matthew Holden, Amanda Restell Mand, Jun Li, Shaya Anderson, Ming Bi, Julia Hatler, and et al. 2021. "Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs" Diagnostics 11, no. 7: 1190. https://doi.org/10.3390/diagnostics11071190

Tan, E., Frew, E., Cooper, J., Humphrey, J., Holden, M., Mand, A. R., Li, J., Anderson, S., Bi, M., Hatler, J., Person, A., Mortari, F., Gould, K., & Barry, S. (2021). Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs. Diagnostics, 11(7), 1190. https://doi.org/10.3390/diagnostics11071190